AU3139900A - Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) - Google Patents

Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)

Info

Publication number
AU3139900A
AU3139900A AU31399/00A AU3139900A AU3139900A AU 3139900 A AU3139900 A AU 3139900A AU 31399/00 A AU31399/00 A AU 31399/00A AU 3139900 A AU3139900 A AU 3139900A AU 3139900 A AU3139900 A AU 3139900A
Authority
AU
Australia
Prior art keywords
binding
siglec
bpl
lectin
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU31399/00A
Other languages
English (en)
Inventor
Eleftherios P. Diamandis
George Foussias
George M. Yousef
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mt Sinai Hospital
Original Assignee
Mt Sinai Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mt Sinai Hospital filed Critical Mt Sinai Hospital
Publication of AU3139900A publication Critical patent/AU3139900A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU31399/00A 1999-03-11 2000-03-09 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl) Abandoned AU3139900A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US12426099P 1999-03-11 1999-03-11
US60124260 1999-03-11
US12738699P 1999-04-01 1999-04-01
US60127386 1999-04-01
US14491999P 1999-07-21 1999-07-21
US60144919 1999-07-21
PCT/CA2000/000259 WO2000053747A1 (en) 1999-03-11 2000-03-09 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)

Publications (1)

Publication Number Publication Date
AU3139900A true AU3139900A (en) 2000-09-28

Family

ID=27383080

Family Applications (2)

Application Number Title Priority Date Filing Date
AU31399/00A Abandoned AU3139900A (en) 1999-03-11 2000-03-09 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
AU31398/00A Abandoned AU3139800A (en) 1999-03-11 2000-03-09 Novel human kallikrein-like genes

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU31398/00A Abandoned AU3139800A (en) 1999-03-11 2000-03-09 Novel human kallikrein-like genes

Country Status (5)

Country Link
EP (1) EP1159431A2 (https=)
JP (1) JP2002538789A (https=)
AU (2) AU3139900A (https=)
CA (2) CA2362885A1 (https=)
WO (2) WO2000053747A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CA2503475A1 (en) * 1998-12-01 2000-06-08 Genentech, Inc. Promotion or inhibition of angiogenesis and cardiovascularization
CA2360073C (en) 1999-01-28 2011-01-18 Gen-Probe Incorporated Probes and primers for detecting prostate specific antigen (psa) in a biological sample
US7034132B2 (en) 2001-06-04 2006-04-25 Anderson David W Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU7753700A (en) * 1999-10-07 2001-05-10 Schering Aktiengesellschaft Dna encoding prost 07 polypeptide
JP2004512540A (ja) 2000-11-01 2004-04-22 マウント・サイナイ・ホスピタル 卵巣癌の検出
EP1661986A1 (en) * 2000-11-17 2006-05-31 Nuvelo, Inc. Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides
AUPR402201A0 (en) * 2001-03-27 2001-04-26 Queensland University Of Technology Polynucleotides and polypeptides linked to cancer and/or benign tumours
US20030104455A1 (en) * 2001-11-07 2003-06-05 Millennium Pharmaceuticals, Inc. Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524
CA2497061A1 (en) * 2002-08-28 2004-03-11 Mount Sinai Hospital Methods for detecting endocrine cancer using kallikrein 13 (klk13) as a biomarker
WO2005021781A2 (en) * 2003-08-30 2005-03-10 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with kallikrein 9 (klk9)
EP1721003A1 (en) * 2004-02-18 2006-11-15 Bayer HealthCare AG Diagnostics and therapeutics for diseases associated with kallikrein 5 (klk5)
US20130315891A1 (en) * 2012-05-25 2013-11-28 Matthew Charles Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
EP2854841B1 (en) 2012-06-04 2017-02-22 Diamedica Inc. Human tissue kallikrein 1 glycosylation isoforms
WO2017123745A1 (en) * 2016-01-12 2017-07-20 Palleon Pharma Inc. Use of siglec-7 or siglec-9 antibodies for the treatment of cancer
CN110446501A (zh) 2017-03-09 2019-11-12 代阿麦迪卡股份有限公司 组织激肽释放酶1的剂型
CN112480237B (zh) * 2019-09-12 2023-10-17 上海津曼特生物科技有限公司 一种融合蛋白及其制备方法和应用
CN114414812B (zh) * 2020-12-21 2022-09-20 华中科技大学同济医学院附属同济医院 生物标志物组合在制备暴发性心肌炎诊断试剂及暴发性心肌炎药物方面的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5786148A (en) * 1996-11-05 1998-07-28 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a novel prostate-specific kallikrein
EP0869178A1 (en) * 1997-04-02 1998-10-07 Smithkline Beecham Corporation SAF-3, Sialoadhesin family member-3
US6146845A (en) * 1997-04-02 2000-11-14 Smithkline Beecham Corporation Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
NZ531664A (en) * 1998-09-01 2005-07-29 Genentech Inc Pro1317 polypeptides and sequences thereof with homology to the semaphorin B glycoprotein family
KR100529270B1 (ko) * 1998-12-01 2005-11-21 제넨테크, 인크. 혈관신생 및 심혈관형성의 촉진 또는 억제

Also Published As

Publication number Publication date
WO2000053747A1 (en) 2000-09-14
WO2000053776A3 (en) 2000-12-14
CA2366087A1 (en) 2000-09-14
CA2362885A1 (en) 2000-09-14
EP1159431A2 (en) 2001-12-05
JP2002538789A (ja) 2002-11-19
WO2000053776A2 (en) 2000-09-14
AU3139800A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
AU3139900A (en) Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
AU6324300A (en) Releasable connector
AU4978000A (en) Head-up display
AU5788299A (en) Seed-preferred promoters from (end) genes
AU7824000A (en) Micro-electro-mechanical gyroscope
AU2002323634A1 (en) Flexible delivery system
AU2002250133A1 (en) Improved aircraft system architecture
AU4998400A (en) Docking assembly
AU2925600A (en) Genetic screening
AU7956100A (en) Head-mounted display system
AU1564501A (en) Display system
AU4819800A (en) Transducer connector
AU2002244071A1 (en) Expression system for seed proteins
AU2495300A (en) Lentivirus vector system
AU7435500A (en) Adenoviral vectors
AU2002218931A1 (en) Modular scaleable floating system
AU2869300A (en) Fiber receptor-independent system for the propagation of adenoviral vectors
WO2000061614A8 (en) Uncoupling proteins
AU1314801A (en) Non-incendiary displays
AU4352000A (en) Clasp-2 transmembrane proteins
AU4995099A (en) Co-axial joint system
AU5833100A (en) Survival jacket
AU7372498A (en) Entomopoxvirus-based gene delivery vector for vertebrates
AU6911300A (en) Isomerase proteins
AU1992900A (en) Docking arrangement

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase